AE

Aegerion Pharmaceuticals

- NASDAQ:AEGR
  • Aegerion Pharmaceuticals engages in the development of therapeutics and pharmaceuticals to treat cardiovascular and metabolic diseases.

  • Locations

    • Cambridge MA

  • Total Funding (USD)

    63.7 million

  • Acquisitions (3)

    • Aegerion Pharmaceuticals (2019)
    • Aegerion Pharmaceuticals (2016)
    • Myalept (2014)
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo